S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)

Quotient Stock Forecast, Price & News

+0.05 (+2.44%)
(As of 01/14/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
545,615 shs
Average Volume
416,580 shs
Market Capitalization
$214.82 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive QTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter.

Quotient logo

About Quotient

Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland.


VOE: Of Neutral Value - Seeking Alpha
January 15, 2022 |  seekingalpha.com
Quotient (QTNT) Upgraded to Buy: Here's What You Should Know
December 31, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Diagnostic substances
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$43.38 million
Book Value
($0.35) per share


Net Income
$-111.03 million
Net Margins
Pretax Margin




Free Float
Market Cap
$214.82 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.24 out of 5 stars

Medical Sector

327th out of 1,417 stocks

Diagnostic Substances Industry

3rd out of 25 stocks

Analyst Opinion: 3.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

Quotient (NASDAQ:QTNT) Frequently Asked Questions

Is Quotient a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Quotient stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTNT, but not buy additional shares or sell existing shares.
View analyst ratings for Quotient
or view top-rated stocks.

How has Quotient's stock price been impacted by COVID-19 (Coronavirus)?

Quotient's stock was trading at $4.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, QTNT stock has decreased by 54.7% and is now trading at $2.10.
View which stocks have been most impacted by COVID-19

When is Quotient's next earnings date?

Quotient is scheduled to release its next quarterly earnings announcement on Monday, February 7th 2022.
View our earnings forecast for Quotient

How were Quotient's earnings last quarter?

Quotient Limited (NASDAQ:QTNT) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.28) earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.28). The company earned $9.47 million during the quarter, compared to analysts' expectations of $8.30 million.
View Quotient's earnings history

What price target have analysts set for QTNT?

1 brokerages have issued twelve-month price targets for Quotient's shares. Their forecasts range from $3.50 to $3.50. On average, they expect Quotient's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 66.7% from the stock's current price.
View analysts' price targets for Quotient
or view top-rated stocks among Wall Street analysts.

Who are Quotient's key executives?

Quotient's management team includes the following people:
  • Manuel O. Méndez Muñiz, Chief Executive Officer & Director
  • Ali J. Kiboro, Chief Financial Officer
  • Christine Ginocchio, Chief Scientific & Medical Officer
  • Mohammad El Khoury, Chief Commercial Officer
  • Christian Albrich, Chief People Officer

What other stocks do shareholders of Quotient own?

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $2.10.

How much money does Quotient make?

Quotient has a market capitalization of $214.82 million and generates $43.38 million in revenue each year. The company earns $-111.03 million in net income (profit) each year or ($1.20) on an earnings per share basis.

How many employees does Quotient have?

Quotient employs 435 workers across the globe.

What is Quotient's official website?

The official website for Quotient is www.quotientbd.com.

Where are Quotient's headquarters?

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The company can be reached via phone at (122) 716-9800 or via email at [email protected].

This page was last updated on 1/17/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.